- “We have done nothing wrong.”
- “No regulator has raised concerns / criticised the process.”
Those two assertions go to the heart of why this warrants FT and wider media coverage. Ordinary investors (pensioners, ISA/SIPP holders, parents saving for their children) have suffered life-changing losses following a 40–50% price collapse triggered not by macro news but by the company’s own transaction structure. Yet management’s message is effectively nothing to see here, and the absence of visible regulatory action is being used as a shield.
This isn’t a valuation spat; it is a question of market integrity with clear public interest as to:
- whether the UK’s rules meaningfully protect minority shareholders
- whether regulatory silence can be cited as exoneration when outcomes look coercive to the investing public
I would be grateful if the FT and other media could give this the wider airing it merits and have written to them and to my MP to that effect. I await with interest if there is any follow up.
Please do send me an email if you support the actions of the Anexo shareholder group.
Cliff Weight, member of ShareSoc and of ShareSoc’s Education and Policy & Campaigns Committees.
DISCLOSURE: The author holds shares in Anexo
Initial disclaimer for blog posts: This article reflects the opinions of its author and not necessarily those of ShareSoc.